Business
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Hi, what are you looking for?
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
Tamir Capital is invested in Proneuron, which successfully sued Teva for abuse of a license for its product.
Despite the ongoing two-month strike, Israel Chemicals has agreed to supply Chinese customers with the potash in 2015.
– The agreement gives Medivation the license to develop and commercialize Curetech’s pidilizumab cancer treatment. – Medivation has decided to exercise the option...
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target...
– A drilling test near Haifa revealed corundum, sapphire, rubies, and moissanite. – Shefa Yamim Ltd. (TASE: SEFA) today published the findings from the...
– The group is considering various possibilities for selling its stake in Clal Insurance in whole or in part. – The IDB group...
Discount Investment posted a net loss of about $184 million in the third quarter. Discount Investment Corporation (TASE: DISI), controlled by Eduardo Elsztain and...
– The Bank of Israel unexpectedly purchased foreign currency after reporting that foreign exchange reserves fell in September. – The Bank of Israel...